| 0 | ℹ |
Long-term treatment durability and safety after switching to bictegravir/emtricitabine/tenofovir alafenamide in real-world practice: a 144-week update from the BICTEL cohort.
(linkinghub.elsevier.com)
|
International Journal of Antimicrobial Agents 2026-08-28 | #hiv #safety #adherence #cohort study |